28 results
S-1/A
EX-10.8
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
in the Exchange Agreement.
“Expert” means a “Big 4” accounting firm not disqualified by conflicts or independence analysis or such nationally recognized … expert in the particular area of disagreement as is mutually acceptable to both parties.
“GTCR Blocker” has the meaning set forth in the recitals
8-K
EX-10.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
Unit” has the meaning set forth in the Exchange Agreement.
“Expert” means a “Big 4” accounting firm not disqualified by conflicts or independence … analysis or such nationally recognized expert in the particular area of disagreement as is mutually acceptable to both parties.
“GTCR Blocker” has
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
associated with that role. Dr. DeFord, a medical technology expert, was appointed to fill the vacancy.
Dr. DeFord is the Chairman, Chief Executive Officer
DRS/A
EX-10.20
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Draft registration statement (amended)
12:00am
WITH COMPLEX TRANSACTIONS ARE MOST QUICKLY
AND ECONOMICALLY RESOLVED BY AN EXPERIENCED AND EXPERT PERSON AND THE PARTIES HERETO WISH APPLICABLE STATE
S-1
EX-10.20
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
IPO registration
5:04pm
WITH COMPLEX TRANSACTIONS ARE MOST QUICKLY
AND ECONOMICALLY RESOLVED BY AN EXPERIENCED AND EXPERT PERSON AND THE PARTIES HERETO WISH APPLICABLE STATE
8-K
EX-99.1
znlltslm
7 Aug 23
Maravai Lifesciences Reports Second Quarter 2023 Financial Results
4:19pm
8-K
EX-3.2
rk2ne hf89
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-1/A
EX-3.2
phw5fw4onp0
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.12
gkhxx3yeix kqr
9 Nov 20
IPO registration (amended)
2:05pm
S-1
EX-10.22
0ma2mtmca7p0p k6gt0k
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.22
r5lsezwps61pjvb
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.23
vkdu7ev15q8u ufc36
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.23
11094q1e1shv1ki2t8t
29 Oct 20
IPO registration
5:04pm
S-1/A
EX-10.9
eybu4x6a95klosm
9 Nov 20
IPO registration (amended)
2:05pm
8-K
EX-10.2
x6dv8n6g rxkyehu
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-1
EX-10.21
cay1q
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.21
bl8ky
14 Oct 20
Draft registration statement (amended)
12:00am
S-1/A
EX-10.10
lrox45 jfn6dxj3ur6e
9 Nov 20
IPO registration (amended)
2:05pm
8-K
EX-10.3
3higl428vm 62b977
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am